Navigation Links
Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program
Date:2/8/2008

Clinical Experts To Oversee Phase 3 Program of CGT-2168

MENLO PARK, Calif., Feb. 8 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc., today named a distinguished international panel of medical experts to serve on the Scientific Steering Committee charged with overseeing COGENT, the company's global Phase 3 clinical trial program for its novel combination antiplatelet product CGT-2168.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/COGENTUSLOGO)

The panel includes experts in the fields of cardiology, gastroenterology and clinical investigation. "We are extremely pleased that these accomplished clinical scientists will advise us on the COGENT program. Their participation will help ensure its scientific success," said Cogentus Chairman and Chief Executive Officer Mark A. Goldsmith, M.D., Ph.D.

Members of the COGENT Scientific Steering Committee are:

-- Dr. Deepak Bhatt, Associate Director, Cardiovascular Coordinating

Center, Cleveland Clinic, Cleveland, Ohio

-- Dr. Marc Cohen, Director of the Division of Cardiology, Newark Beth

Israel Medical Center, Newark, New Jersey

-- Dr. Byron Cryer, John C. Vanatta III Professor of Medicine and

Associate Dean for Minority Affairs, Southwestern Medical School,

Dallas, Texas

-- Dr. Angel Lanas, Service of Gastroenterology, University Hospital,

Zaragoza, Spain

-- Dr. Thomas Schnitzer, Professor of Medicine, Division of Rheumatology,

Northwestern University Feinberg School of Medicine, Chicago, Illinois

The Scientific Steering Committee will be responsible for providing scientific and clinical oversight and advice to ensure the data that emerge from the COGENT program are of the highest quality and that the highest level of scientific conduct is maintained.

The ongoing COGENT program will evaluate the ef
'/>"/>

SOURCE Cogentus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cogentus Pharmaceuticals Completes $62.5 Million Private Financing
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... (PRWEB) April 18, 2015 Lowcostcarinsuranceprice.com has ... theft rates have on auto insurance prices . ... high rates of vehicle theft may have to pay ... Some liability auto insurance policies can also offer protection ... can now be compared online on a single website: ...
(Date:4/18/2015)... April 18, 2015 Patients who undergo ... developing mesothelioma later in life, but the disease is ... that is unrelated to radiation. Surviving Mesothelioma has just ... website. Click here to read it now. ... the cases of 45 patients who had both a ...
(Date:4/18/2015)... In the past few weeks, TheBeautyPlace.com has been ... had to run maintenance on our shipping facilities to ... the PR Director. "It disrupted our regular shipping schedule ... back on track after having completed the maintenance." , ... systems which has not allowed some calls to come ...
(Date:4/18/2015)... On April 14th, 2015, Symantec released Volume 20 ... “exposes a tactical shift by cyberattackers.” With everything from frightening ... 2014 - almost a million a day - to how ... and patched by prominent manufacturers – as long as 204 ... a digital world can be fraught with peril, and that ...
(Date:4/18/2015)... “ ArcAngel ” was featured on NewsWatch as part ... latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... In a turbulent world, people may find themselves in dangerous ... their first move, but some situations can be avoided if ...
Breaking Medicine News(10 mins):Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Temporary Number Available 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:A Personal Safety Application was Featured on NewsWatch Television 2
... DALLAS June 3, 2009 A simple magnetic resonance ... the best treatment for some cancer patients, report researchers at ... that the amount of oxygen present in a tumor can ... to treatment. Tumors with little oxygen tend to grow stronger ...
... 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical,Inc. ("China Sky ... ), a leading,fully integrated pharmaceutical company producing over-the-counter drugs ... it obtained,approval from the State Food and Drug Administration ... drops. The document number for the drug is,2009S02063. , ...
... , This release is available in <A ... induce cells from pigs to transform into pluripotent stem ... capable of developing into any type of cell in ... world that this has been achieved using somatic cells ...
... than 25 years of experience to support growing demand ... June 2 Covance Inc. today announced Monte Jarvis ... for periapproval services. With more than 25 years ... global data management, Jarvis will oversee data management and ...
... June 2 The National Press Club Newsmaker ... Wednesday, June 3, with Argonne National Laboratory Director ... and cannot travel to Washington. , , ... ) , , The press conference ...
... Foundation,s Annual Salute to Service Award , , ... consecutive year, Jim Kerwin of Oxford Communications ( www.oxfordcommunications.bm ... that Oxford Communications will be the primary sponsor of ... Luncheon on June 17th and Celebrity Golf Tournament to ...
Cached Medicine News:Health News:Oxygen + MRI might help determine cancer therapy success, researchers find 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 2Health News:China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops 3Health News:World first: Chinese scientists create pig stem cells 2Health News:World first: Chinese scientists create pig stem cells 3Health News:Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services 2Health News:Covance Announces Monte Jarvis as Vice President of Global Data Management and Biostatistics for Periapproval Services 3Health News:Jim Kerwin Announces Oxford Communications To Be the Title Sponsor of Bermuda Health Foundation Salute for the Second Year 2
(Date:4/17/2015)... ADELAIDE, Australia , April 17, 2015 ... the discovery and development of innovative therapeutics for the ... system, today announced the presentation of data from three ... American Association for Cancer Research (AACR) 106 th ... Philadelphia, PA USA. ...
(Date:4/16/2015)... , April 16, 2015  Hologic, Inc. ... cervical cancer screening study i published on-line ... peer-reviewed journal of the American Cancer Society. ... and the University of Pittsburgh Medical Center, supports current consensus ... recommend that women 30-65 years of age be ...
(Date:4/16/2015)... , April 16, 2015  Diplomat Pharmacy, Inc. ... Shannon Beltrand to their senior leadership team as ... be responsible for securing and properly monitoring Diplomat,s data, ... both internally and externally. Additionally, she will play key ... "We are very excited to have someone ...
Breaking Medicine Technology:Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Diplomat Names Shannon M. Beltrand as New CISO 2
... The Coolscope operates with a simple ... monitor display. Direct the mouse cursor ... macro image of the slide and ... The intuitive Graphic User Interface (GUI) ...
Advanced ergonomic design allows greater comfort even after long hours of use. The focus knob and stage handle are located equidistant from the operator, permitting one-handed operation in a natural ...
... laboratory microscope whose superior ergonomics, ... to make it the ideal ... designed to fit the user ... to fit the microscope. Optimized ...
Carbide drill bits, cutters, side cutting. Available in various sizes....
Medicine Products: